Exosens SAS [EXENS] vs Nexans S.A [NEX] Detailed Stock Comparison

Exosens SAS

EURONEXT
Loading...

Nexans S.A.

EURONEXT
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Exosens SAS wins in 6 metrics, Nexans S.A. wins in 12 metrics, with 0 ties. Nexans S.A. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Exosens SAS Nexans S.A. Better
P/E Ratio (TTM) 95.15 28.95 Nexans S.A.
Price-to-Book Ratio 7.25 3.01 Nexans S.A.
Debt-to-Equity Ratio 59.79 94.34 Exosens SAS
PEG Ratio 28.68 15.60 Nexans S.A.
EV/EBITDA 26.59 9.66 Nexans S.A.
Profit Margin (TTM) 9.12% 4.51% Exosens SAS
Operating Margin (TTM) 22.24% 5.90% Exosens SAS
EBITDA Margin (TTM) 22.24% 5.90% Exosens SAS
Return on Equity 16.36% 11.44% Exosens SAS
Return on Assets (TTM) 7.67% 3.67% Exosens SAS
Free Cash Flow (TTM) $107.40M $464.00M Nexans S.A.
Dividend Yield 0.23% 2.61% Nexans S.A.
1-Year Return 39.86% 45.61% Nexans S.A.
Price-to-Sales Ratio (TTM) 6.93 0.77 Nexans S.A.
Enterprise Value $3.43B $6.29B Nexans S.A.
EV/Revenue Ratio 7.33 0.81 Nexans S.A.
Gross Profit Margin (TTM) 59.20% N/A N/A
Revenue per Share (TTM) $9 $179 Nexans S.A.
Earnings per Share (Diluted) $0.67 $4.75 Nexans S.A.
Beta (Stock Volatility) N/A 0.76 N/A

Exosens SAS vs Nexans S.A. Stock Performance Analysis

Loading Price Chart...

EXENS
NEX

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Exosens SAS-2.18%-4.66%0.95%-18.62%27.96%16.70%
Nexans S.A.1.64%-3.64%-9.24%24.52%17.98%15.59%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Exosens SAS39.86%165.11%165.11%165.11%165.11%165.11%
Nexans S.A.45.61%78.80%105.49%235.48%408.54%408.54%

Performance & Financial Health Analysis: Exosens SAS vs Nexans S.A.

MetricEXENSNEX
Market Information
Market Cap i€3.25B€6.01B
Market Cap CategoryLarge capLarge cap
10 Day Avg. Volume i105,345158,343
90 Day Avg. Volume i155,243146,359
Last Close€58.35€148.30
52 Week Range€36.20 - €74.00€95.05 - €169.00
% from 52W High-21.15%-12.25%
All-Time High€74.00 (Mar 18, 2026)€167.60 (May 07, 2026)
% from All-Time High-21.15%-11.52%
Growth Metrics
Quarterly Revenue Growth0.16%N/A
Quarterly Earnings GrowthN/AN/A
Financial Health
Profit Margin (TTM) i0.09%0.05%
Operating Margin (TTM) i0.22%0.06%
Return on Equity (TTM) i0.16%0.11%
Debt to Equity (MRQ) i59.7994.34
Cash & Liquidity
Book Value per Share (MRQ)€8.79€45.70
Cash per Share (MRQ)€1.35€37.43
Operating Cash Flow (TTM) i€100.00M€847.00M
Levered Free Cash Flow (TTM) i€50.74M€418.00M
Dividends
Last 12-Month Dividend Yield i0.23%2.61%
Last 12-Month Dividend i€0.10€2.60

Valuation & Enterprise Metrics Analysis: Exosens SAS vs Nexans S.A.

MetricEXENS (Apr 26, 2026)NEX (Apr 26, 2026)
Price Ratios
P/E Ratio (TTM) i95.1528.95
Forward P/E i28.6815.60
PEG Ratio i28.6815.60
Price to Sales (TTM) i6.930.77
Price to Book (MRQ) i7.253.01
Market Capitalization
Market Capitalization i€3.25B€6.01B
Enterprise Value i€3.43B€6.29B
Enterprise Value Metrics
Enterprise to Revenue i7.330.81
Enterprise to EBITDA i26.599.66
Risk & Other Metrics
Beta iN/A0.76
Book Value per Share (MRQ) i€8.79€45.70

Financial Statements Comparison: Exosens SAS vs Nexans S.A.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricEXENS (2025)NEX (2025)
Revenue/Sales i383.40M7.81B
Cost of Goods Sold i161.10M6.90B
COGS % of Revenue i42.0%88.4%
Gross Profit i222.30M907.00M
Gross Margin i58.0%11.6%
Research & Development iN/A54.00M
Operating Income (EBIT) i80.60M425.00M
Operating Margin i21.0%5.4%
EBITDA i120.10M664.00M
EBITDA Margin i31.3%8.5%
Pre-Tax Income i45.80M316.00M
Pre-Tax Income % of Revenue i11.9%4.0%
Income Tax i11.60M97.00M
Income Tax % of Revenue i3.0%1.2%
Net Income (Profit) i30.70M358.00M
Profit Margin i8.0%4.6%

Balance Sheet & Liquidity Metrics

MetricEXENS (2025)NEX (2025)
Cash & Equivalents i68.60M1.63B
Total Current Assets i280.20M4.69B
Total Current Assets % of Revenue i73.1%60.0%
Total Current Liabilities i113.70M3.83B
Total Current Liabilities % of Revenue i29.7%49.1%
Long-Term Debt i13.60M1.69B
Long-Term Debt % of Revenue i3.5%21.6%
Total Shareholders Equity i445.60M2.01B
Retained Earnings iN/AN/A
Retained Earnings % of Revenue i0.0%0.0%
Property, Plant & Equipment i128.10MN/A

Cash Flow Statement Comparison

MetricEXENS (2025)NEX (2025)
Operating Cash Flow i88.80M335.00M
Operating Cash Flow % of Revenue i23.2%4.3%
Capital Expenditures iN/A2.00M
Free Cash Flow i107.40M464.00M
FCF Margin i28.0%5.9%
Debt Repayment iN/AN/A
Common Stock Repurchase i-8.80MN/A

Short Interest & Institutional Ownership Analysis

MetricEXENSNEX
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i50.76M43.68M
Float Shares i32.61M38.06M
% Held by Insiders i28.29%8.09%
% Held by Institutions i45.28%66.69%
% Held by Public i26.43%25.22%

Dividend Analysis & Yield Comparison: Exosens SAS vs Nexans S.A.

MetricEXENSNEX
Last 12-Month Dividend i€0.10€2.60
Last 12-Month Dividend Yield i0.23%2.61%
3-Year Avg Annual Dividend i€0.03€2.33
3-Year Avg Dividend Yield i0.23%2.47%
3-Year Total Dividends i€0.10€7.00
Ex-Dividend DateMay 28, 2025May 19, 2025